Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7802
-0.0023 (-0.29%)
At close: Feb 19, 2026, 4:00 PM EST
0.7900
+0.0098 (1.26%)
Pre-market: Feb 20, 2026, 9:06 AM EST
Skye Bioscience Employees
Skye Bioscience had 16 employees as of December 31, 2024. The number of employees increased by 5 or 45.45% compared to the previous year.
Employees
16
Change (1Y)
5
Growth (1Y)
45.45%
Revenue / Employee
n/a
Profits / Employee
-$3,201,833
Market Cap
25.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | 2 | 50.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Cue Biopharma | 41 |
| Senti Biosciences | 34 |
| Daré Bioscience | 23 |
| Rallybio | 15 |
| Neuphoria Therapeutics | 8 |
SKYE News
- 17 days ago - Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year - Benzinga
- 18 days ago - Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide - GlobeNewsWire
- 22 days ago - Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference - GlobeNewsWire
- 4 weeks ago - Skye Bioscience to Present Poster at Keystone Obesity Conference - GlobeNewsWire
- 4 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile Corp
- 5 weeks ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewsWire
- 5 weeks ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile Corp
- 5 weeks ago - Skye Provides 2026 Corporate Outlook - GlobeNewsWire